Molecular Diagnostics

Molecular diagnostics is one of the most dynamic and transformative areas of human diagnostics, leading to advances in research and treatment that are revolutionizing health care across a wide range of diseases and health conditions.

ANTISEL offers the appropriate tools, the advanced services and the scientific partnership that enable your Lab by offering to clinician the correct molecular test result in every stage of care, Risk assessment, Screening, Diagnosis, Prognosis Therapy Selection and Monitoring. ANTISEL’s team not only provides updated key technologies for molecular diagnostics but also familiarizes your Lab with the nucleic acid handling while whole human genome sequencing in Clinical Diagnostics is not far away.

Microbiology/Virology

ANTISEL with the extended portfolio of high end systems and genetic apparatus for microorganism covers the need in molecular diagnosis of pro and eukaryotic molecular microbiology and molecular virology.

Pathology

ANTISEL is on the way to dominate in the field of anatomic pathology and immunohistochemistry. The combination of our highly trained and experienced team with our suppliers, well recognized in Europe as well as in US, offers integrated solutions customized to every specific need of your Lab.

Genetics

ANTISEL Stays tuned for cutting-edge clinical research in areas such as genomics, chromosome abnormalities, metabolic diseases, single gene disorders and genetic aspects of common complex diseases.

Immunology/Transplantation

ANTISEL is the leader supplier in transplant diagnostics providing a broad portfolio of molecular and antibody-based assays to evaluate HLA compatibility between donors and recipients. We remain focused on continuing to innovate as we work to advance the technology of transfusion and transplantation diagnostics. A very highly educated and trained team as well as very professional field engineers support your daily routine offering the highest level of services.

Oncology/Hematology

ANTISEL follows very closely all the discoveries to current cancer genetic and genomic for both somatic and germline mutations that are utilized to better understand the underlying biology of cancer growth and treatment response as well as cancer risk assessment. The tremendous gains in the knowledge of the structure and function of human genes will surely impact the diagnosis, prognosis and treatment of cancer.